These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New trends in Clostridium difficile virulence and pathogenesis. Denève C; Janoir C; Poilane I; Fantinato C; Collignon A Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565 [TBL] [Abstract][Full Text] [Related]
5. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice. Mahe S; Corthier G; Dubos F Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315 [TBL] [Abstract][Full Text] [Related]
6. Microbiology, epidemiology and diagnosis of Clostridium difficile infection. Brazier JS; Borriello SP Curr Top Microbiol Immunol; 2000; 250():1-33. PubMed ID: 10981355 [No Abstract] [Full Text] [Related]
7. Clostridium difficile and the disease it causes. Norén T Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838 [TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744 [TBL] [Abstract][Full Text] [Related]
10. Outbreak from a high-toxin intruder: Clostridium difficile. Norén T Lancet; 2005 Sep 24-30; 366(9491):1053-4. PubMed ID: 16182878 [No Abstract] [Full Text] [Related]
13. Contamination and crossinfection with Clostridium difficile in an intensive care unit. Walters BA; Stafford R; Roberts RK; Seneviratne E Aust N Z J Med; 1982 Jun; 12(3):255-8. PubMed ID: 6956292 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes. Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543 [TBL] [Abstract][Full Text] [Related]
15. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies. Lamont JT Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania. Rafila A; Indra A; Popescu GA; Wewalka G; Allerberger F; Benea S; Badicut I; Aschbacher R; Huhulescu S J Infect Dev Ctries; 2014 Jun; 8(6):694-8. PubMed ID: 24916866 [TBL] [Abstract][Full Text] [Related]
17. 12th C. L. Oakley lecture. Pathogenesis of Clostridium difficile infection of the gut. Borriello SP J Med Microbiol; 1990 Dec; 33(4):207-15. PubMed ID: 2258909 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. Aronsson B; Möllby R; Nord CE J Infect Dis; 1985 Mar; 151(3):476-81. PubMed ID: 3973405 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Fekety R; Kim KH; Brown D; Batts DH; Cudmore M; Silva J Am J Med; 1981 Apr; 70(4):906-8. PubMed ID: 7211925 [TBL] [Abstract][Full Text] [Related]
20. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]